Drug Burden Index and Clinical Outcomes
A measure of an individual’s total exposure to anticholinergic and sedative medications, a higher Drug Burden Index (DBI) is associated with an increased risk of
A measure of an individual’s total exposure to anticholinergic and sedative medications, a higher Drug Burden Index (DBI) is associated with an increased risk of
“Version 3 of the STOPP/START criteria is a welcome addition to geriatric pharmacotherapy,” write authors of a commentary. “The START criteria are a unique tool
“Deprescribing is the medically supervised process of decreasing or stopping medications that are no longer needed or may be causing harm,” advises a JAMA Patient
In the large, 6-month Care Homes Independent Pharmacist Prescriber Study (CHIPPS), weekly visits to care homes by pharmacist independent prescribers (PIPs) significantly reduced the Drug Burden
Studies of deprescribing interventions can be improved through steps as simple as “clearly defining clinically meaningful medication outcomes (e.g., number of chronic medications, dose reductions),